Aug 9, 2022 | News first column
CHUV and EPFL have discovered a new monoclonal antibody that neutralizes the Omicron variants of SARS-CoV-2. This work, published in Nature Microbiology, opens the way to new prophylactic and therapeutic applications. This new antibody confers complete protection in...
Apr 28, 2022 | Publications
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C...
Apr 26, 2022 | Publications
T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling
Dec 6, 2021 | Publications
PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice